Lauria F - Search Results

1

Hodgkin's disease (HD): a historical perspective.

Tura S, Mazza P, Zinzani PL, Verlicchi F, Baccarani M, Lauria F, Fiacchini M, Gobbi M, Bandini G, Emiliani E, et al. Tura S, et al. Among authors: lauria f. Eur J Cancer Clin Oncol. 1986 Nov;22(11):1315-23. doi: 10.1016/0277-5379(86)90139-2. Eur J Cancer Clin Oncol. 1986. PMID: 2435555

2

Prognostic significance of lymphography in stage IIIs Hodgkin's disease (HD).

Mazza P, Miniaci G, Lauria F, Gobbi M, Emiliani E, Barbieri E, Neri S, Querzani P, Fiacchini M, Tura S. Mazza P, et al. Among authors: lauria f. Eur J Cancer Clin Oncol. 1984 Nov;20(11):1393-9. doi: 10.1016/0277-5379(84)90058-0. Eur J Cancer Clin Oncol. 1984. PMID: 6542008

3

Management of nodular sclerosis Hodgkin's disease stage I, II A and B: evidence for a beneficial effect of MOPP on the relapse rate.

Lauria F, Baccarani M, Babini L, Emiliani E, Fiacchini M, Gobbi M, Mazza P, Sciascia R, Tura S. Lauria F, et al. Acta Haematol. 1979;62(5-6):262-6. doi: 10.1159/000207585. Acta Haematol. 1979. PMID: 121667 Clinical Trial.

4

Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma.

Lauria F, Baccarani M, Fiacchini M, Gobbi M, Tura S. Lauria F, et al. Eur J Cancer (1965). 1975 May;11(5):343-9. doi: 10.1016/0014-2964(75)90062-6. Eur J Cancer (1965). 1975. PMID: 1098915 No abstract available.

5

Lymphoblastic lymphoma in adolescents and adults. Clinical, pathological and prognostic evaluation.

Mazza P, Bertini M, Macchi S, Lauria F, Pileri S, Rivano MT, Baccarani M, Ricci P, Fiacchini M, Vitolo U, et al. Mazza P, et al. Among authors: lauria f. Eur J Cancer Clin Oncol. 1986 Dec;22(12):1503-10. doi: 10.1016/0277-5379(86)90087-8. Eur J Cancer Clin Oncol. 1986. PMID: 3496223

6

High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma.

Tura S, Mazza P, Gherlinzoni F, Ricci P, Visani G, Bandini G, Zaccaria A, Rosti G, Lauria F, Baccarani M, et al. Tura S, et al. Among authors: lauria f. Scand J Haematol. 1986 Oct;37(4):347-52. doi: 10.1111/j.1600-0609.1986.tb02325.x. Scand J Haematol. 1986. PMID: 3538369

7

Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas.

Zinzani PL, Gherlinzoni F, Lauria F, Mazza P, Barbieri E, Emiliani E, Tabanelli M, Tura S. Zinzani PL, et al. Among authors: lauria f. Tumori. 1987 Apr 30;73(2):121-6. doi: 10.1177/030089168707300206. Tumori. 1987. PMID: 3576707

8

Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implications.

Tura S, Mazza P, Lauria F, Fiacchini M, Pileri S, Poletti G, Gherlinzoni F, Cantore M, Bandini G. Tura S, et al. Among authors: lauria f. Scand J Haematol. 1985 Aug;35(2):123-31. doi: 10.1111/j.1600-0609.1985.tb01560.x. Scand J Haematol. 1985. PMID: 3876594

9

Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.

Fiacchini M, Lauria F, Mazza P, Cantore M, Gherlinzoni F, Tura S. Fiacchini M, et al. Among authors: lauria f. Haematologica. 1985 Mar-Apr;70(2):148-54. Haematologica. 1985. PMID: 3924778 No abstract available.

10

Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long-lasting remission.

Lauria F, Foa R, Gobbi M, Camaschella C, Lusso P, Raspadori D, Tura S. Lauria F, et al. Cancer. 1983 Oct 15;52(8):1385-8. doi: 10.1002/1097-0142(19831015)52:8<1385::aid-cncr2820520808>3.0.co;2-7. Cancer. 1983. PMID: 6225507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters